ConvaTec Group Plc
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostom… Read more
ConvaTec Group Plc (CNVVF) - Total Assets
Latest total assets as of June 2025: $3.77 Billion USD
Based on the latest financial reports, ConvaTec Group Plc (CNVVF) holds total assets worth $3.77 Billion USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
ConvaTec Group Plc - Total Assets Trend (2012–2024)
This chart illustrates how ConvaTec Group Plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
ConvaTec Group Plc - Asset Composition Analysis
Current Asset Composition (December 2024)
ConvaTec Group Plc's total assets of $3.77 Billion consist of 22.6% current assets and 77.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.8% |
| Accounts Receivable | $301.00 Million | 8.6% |
| Inventory | $349.24 Million | 9.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $805.90 Million | 22.9% |
| Goodwill | $1.29 Billion | 36.7% |
Asset Composition Trend (2012–2024)
This chart illustrates how ConvaTec Group Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ConvaTec Group Plc's current assets represent 22.6% of total assets in 2024, an increase from 15.6% in 2012.
- Cash Position: Cash and equivalents constituted 1.8% of total assets in 2024, down from 2.9% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 58.0% of total assets, a decrease from 74.0% in 2012.
- Asset Diversification: The largest asset category is goodwill at 36.7% of total assets.
ConvaTec Group Plc Competitors by Total Assets
Key competitors of ConvaTec Group Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
ConvaTec Group Plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - ConvaTec Group Plc generates 0.65x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, ConvaTec Group Plc generates $5.42 in net profit.
ConvaTec Group Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.95 | 2.26 | 2.30 |
| Quick Ratio | 1.15 | 1.27 | 1.72 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $455.20 Million | $ 482.30 Million | $ 665.30 Million |
ConvaTec Group Plc - Advanced Valuation Insights
This section examines the relationship between ConvaTec Group Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.33 |
| Latest Market Cap to Assets Ratio | 1.73 |
| Asset Growth Rate (YoY) | -5.4% |
| Total Assets | $3.52 Billion |
| Market Capitalization | $6.08 Billion USD |
Valuation Analysis
Above Book Valuation: The market values ConvaTec Group Plc's assets above their book value (1.73 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: ConvaTec Group Plc's assets decreased by 5.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for ConvaTec Group Plc (2012–2024)
The table below shows the annual total assets of ConvaTec Group Plc from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $3.52 Billion | -5.35% |
| 2023-12-31 | $3.71 Billion | +3.39% |
| 2022-12-31 | $3.59 Billion | -2.23% |
| 2021-12-31 | $3.67 Billion | -2.46% |
| 2020-12-31 | $3.77 Billion | +4.34% |
| 2019-12-31 | $3.61 Billion | -1.38% |
| 2018-12-31 | $3.66 Billion | -3.70% |
| 2017-12-31 | $3.80 Billion | +8.17% |
| 2016-12-31 | $3.51 Billion | -7.32% |
| 2015-12-31 | $3.79 Billion | -3.60% |
| 2014-12-31 | $3.93 Billion | -12.34% |
| 2013-12-31 | $4.49 Billion | -0.19% |
| 2012-12-31 | $4.50 Billion | -- |